What did Zoetis pay for GeneSeek (Neogen Animal Genomics)?

Zoetis acquired GeneSeek (Neogen Animal Genomics) for $160.0M in 2026, equivalent to 1.80x revenue. Target revenue was approximately $90.0M.

What does GeneSeek (Neogen Animal Genomics) do?

GeneSeek (Neogen Animal Genomics) is a laboratory services business.

What multiple did Zoetis pay for GeneSeek (Neogen Animal Genomics)?

1.80x revenue, based on disclosed deal value of $160.0M and disclosed financials.

M&A TRANSACTION · 2026

GeneSeek (Neogen Animal Genomics) acquired by Zoetis

$160.0M· 1.80x revenue

Target

GeneSeek (Neogen Animal Genomics)

Acquirer

Zoetis

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$90.0M

EBITDA

—

Deal Value

$160.0M

EV/EBITDA

—

Context

This $160.0M acquisition of GeneSeek (Neogen Animal Genomics) by Zoetis sits in the laboratory services sub-vertical. Zoetis is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the GeneSeek (Neogen Animal Genomics) acquisition.

Citation: ExitValue.ai. (2026). GeneSeek (Neogen Animal Genomics) acquired by Zoetis. https://exitvalue.ai/deals/geneseek-neogen-animal-genomics-acquired-by-zoetis-hc-2026-0000